Customized research for NVCN vs. YMAB!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for NVCN vs. YMAB.


↗ Join Our Free Email Newsletter.




Neovasc Inc. vs. Y-mAbs Therapeutics Inc.

Industry Match! Industry of Both NVCN and YMAB:

Health Care/Life Sciences

NVCN
Data Last Updated: 8 hours ago

↻  Update Column 1 to Most Recent

Key Statistics

Cap: 21.342M


P/E: N/A

P/S: 9.4

Q P/B: N/A

Y Rev: 2.27M

Q Rev: 588,580

Beta: 2.02

NVCN Share Stats

Outstanding Shares

N/A

Float Shares

6.97M

Percent of Float Short

3.09%

NVCN Insider Stats

Percent Outstanding Insider Ownership

N/A

Percent Outstanding Institution Ownership

N/A

NVCN Social Stats

Followers

1

B/S Rating Today

0

B/S Rating All-Time

+2

More Social Data

NVCN in Pulse Portal

Stream of Posts

NVCN Symbol Page

Share NVCN Insights

Express Sentiment

'Buy' or 'Sell' NVCN

NVCN Profile

CEO

Mr. Fredericus Antonius Colen

Exchange

Nasdaq

Employees

98.00

About

Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. Its focuses on Neovast Tiara, and Neovasc Reducer products. The company was founded on November 2, 2000 and is headquartered in Richmond, Canada.

NVCN Financials

Annual Financials

Income Statement

Revenue

2.27M

Net Income

(140.04M)

Cash Flow Statement

Change in Cash / Investments

(10.71M)

Balance Sheet

Cash / Investments

12.62M

Short Term Debt

None

Long Term Debt

18.02M

Total Current Assets

14.67M

Total Current Liabilities

11.3M

Total Assets

16.38M

Total Liabilities

29.58M

Stockholder Equity

(13.2M)

Quarterly Financials

Income Statement

Q Revenue

588,580

Q Net Income

(10.65M)

Cash Flow Statement

Q Change in Cash / Investments

8.31M

Balance Sheet

Q Cash / Investments

23.97M

Q Short Term Debt

None

Q Long Term Debt

10.95M

Q Total Current Assets

25.92M

Q Total Current Liabilities

19.02M

Q Total Assets

28.86M

Q Total Liabilities

33.98M

Q Stockholder Equity

(5.12M)

NVCN Charts

10-Year Chart

NVCN 10-Year Chart

5-Year Chart

NVCN 5-Year Chart

1-Year Chart

NVCN 1-Year Chart

6-Month Chart

NVCN 6-Month Chart

3-Month Chart

NVCN 3-Month Chart

1-Month Chart

NVCN 1-Month Chart

1-Day Chart

NVCN 1-Day Chart

YMAB
Data Last Updated: More than a wk ago

↻  Update Column 2 to Most Recent

Key Statistics

Cap: 954.004M


P/E: N/A

P/S: N/A

Q P/B: 7.6

Y Rev: -

Q Rev: -

Beta: N/A

YMAB Share Stats

Outstanding Shares

34.19M

Float Shares

13.49M

Percent of Float Short

5.72%

YMAB Insider Stats

Percent Outstanding Insider Ownership

N/A

Percent Outstanding Institution Ownership

N/A

YMAB Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

YMAB in Pulse Portal

Stream of Posts

YMAB Symbol Page

Share YMAB Insights

Express Sentiment

'Buy' or 'Sell' YMAB

YMAB Profile

CEO

Mr. Bo Kruse

Exchange

Nasdaq

Employees

32.00

About

Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It develops novel antibody therapeutics for oncology targets. The company's services include discovery, protein engineering, clinical and regulatory. Y-mAbs Therapeutics was founded by Thomas Gad...

YMAB Financials

Annual Financials

Income Statement

Revenue

-

Net Income

(43.27M)

Cash Flow Statement

Change in Cash / Investments

57.36M

Balance Sheet

Cash / Investments

147.87M

Short Term Debt

None

Long Term Debt

None

Total Current Assets

151.53M

Total Current Liabilities

9.12M

Total Assets

151.92M

Total Liabilities

11.4M

Stockholder Equity

140.53M

Quarterly Financials

Income Statement

Q Revenue

-

Q Net Income

(15.93M)

Cash Flow Statement

Q Change in Cash / Investments

(13.6M)

Balance Sheet

Q Cash / Investments

134.28M

Q Short Term Debt

517,000

Q Long Term Debt

None

Q Total Current Assets

137.03M

Q Total Current Liabilities

10.3M

Q Total Assets

140M

Q Total Liabilities

14.48M

Q Stockholder Equity

125.51M

YMAB Charts

10-Year Chart

YMAB 10-Year Chart

5-Year Chart

YMAB 5-Year Chart

1-Year Chart

YMAB 1-Year Chart

6-Month Chart

YMAB 6-Month Chart

3-Month Chart

YMAB 3-Month Chart

1-Month Chart

YMAB 1-Month Chart

1-Day Chart

YMAB 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon